Document is current
Any future updates will be listed below
-
Authors
Runia, Nora https://orcid.org/0000-0002-4611-261X
Bergfeld, Isidoor O. https://orcid.org/0000-0002-0601-7271
de Kwaasteniet, Bart P.
Luigjes, Judy
van Laarhoven, Jan
Notten, Peter
Beute, Guus
van den Munckhof, Pepijn
Schuurman, Rick
Denys, Damiaan
van Wingen, Guido A. https://orcid.org/0000-0003-3076-5891
-
Funding
Funding for this research was provided by:
ZonMw (171201008, 171201008, 171201008, 171201008, 171201008, 171201008, 171201008, 171201008, 171201008, 171201008)
Medtronic (In kind, In kind, In kind, In kind, In kind, In kind, In kind, In kind, In kind, In kind)
- License Information
-
More Information
Article History
Received: 9 September 2022
Revised: 28 February 2023
Accepted: 7 March 2023
First Online: 29 March 2023
Competing interests
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This investigator-initiated study was funded by Medtronic Inc (25 DBS systems, in kind) and a grant from ZonMw (nr. 171201008). The funders had no role in the design, execution, and analysis of the study, nor in writing of the manuscript or the decision to publish. Nora Runia, Isidoor Bergfeld, Pepijn van den Munckhof, Rick Schuurman, Damiaan Denys, and Guido van Wingen currently execute an investigator-initiated clinical trial on deep brain stimulation for depression, which is funded by Boston Scientific (24 DBS systems in kind) and a grant of ZonMw (nr. 636310016). Rick Schuurman acts as consultant for Boston Scientific and Medtronic on educational events. All other authors do not declare any conflicts of interest.
